Carmichael Hill & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Carmichael Hill & Associates’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$148K	Sell	2,860 -536	-16%	-$25.1K	0.05%	219
2024 Q2	$141K	Buy	3,396 +100	+3%	+$4.47K	0.06%	213
2024 Q1	$179K	Hold	3,296	–	–	0.07%	196
2023 Q4	$169K	Sell	3,296 -424	-11%	-$22.3K	0.07%	198
2023 Q3	$216K	Hold	3,720	–	–	0.1%	156
2023 Q2	$238K	Sell	3,720 -948	-20%	-$63.6K	0.11%	151
2023 Q1	$324K	Buy	4,668 +310	+7%	+$21.9K	0.16%	113
2022 Q4	$314K	Hold	4,358	–	–	0.16%	115
2022 Q3	$310K	Buy	4,358 +250	+6%	+$18.1K	0.17%	113
2022 Q2	$316K	Hold	4,108	–	–	0.17%	114
2022 Q1	$300K	Hold	4,108	–	–	0.14%	131
2021 Q4	$256K	Hold	4,108	–	–	0.11%	150
2021 Q3	$243K	Hold	4,108	–	–	0.12%	145
2021 Q2	$274K	Sell	4,108 -811	-16%	-$52.9K	0.14%	133
2021 Q1	$311K	Hold	4,919	–	–	0.17%	114
2020 Q4	$305K	Hold	4,919	–	–	0.18%	109
2020 Q3	$297K	Hold	4,919	–	–	0.2%	104
2020 Q2	$289K	Hold	4,919	–	–	0.21%	98
2020 Q1	$274K	Hold	4,919	–	–	0.24%	84
2019 Q4	$316K	Buy	+4,919	New	+$282K	0.22%	91
2018 Q4	–	Sell	-3,798	Closed	-$236K	–	109
2018 Q3	$236K	Hold	3,798	–	–	0.23%	101
2018 Q2	$210K	Sell	3,798 -388	-9%	-$21K	0.23%	102
2018 Q1	$265K	Hold	4,186	–	–	0.29%	91
2017 Q4	$257K	Buy	+4,186	New	+$262K	0.28%	90

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Carmichael Hill & Associates's BMY Position: Q3 2024 in Review

Carmichael Hill & Associates reduced its Bristol-Myers Squibb (BMY) stake by 16% in Q3 2024, selling an estimated $25.1K and leaving 2,860 shares worth $148K. The position accounts for 0.05% of the portfolio, ranked #219.

Carmichael Hill & Associates first reported a position in BMY in Q4 2017 and has held it in 24 quarters since. The position peaked at $324K in Q1 2023. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

Carmichael Hill & Associates held 2,860 shares of Bristol-Myers Squibb worth $148K as of Q3 2024.
Carmichael Hill & Associates sold 536 Bristol-Myers Squibb shares in Q3 2024, an estimated $25.1K.
Bristol-Myers Squibb made up 0.05% of Carmichael Hill & Associates's portfolio in Q3 2024, its #219 holding.
Carmichael Hill & Associates first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 24 quarters since.
Carmichael Hill & Associates's Bristol-Myers Squibb position peaked at $324K in Q1 2023.
2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.